Search

Your search keyword '"Restrepo, M."' showing total 23 results
Start Over Author "Restrepo, M." Publisher elsevier bv
23 results on '"Restrepo, M."'

1. Donna Jackson-Maldonado. A life dedicated to joining theory and practice in language development research

Author

Auza, Alejandra, primary, Rojas, Cecilia, additional, Simon-Cereijido, Gabriela, additional, Pérez Pereira, Miguel, additional, Aguilar Mediavilla, Eva, additional, Alarcón Neve, Luisa Josefina, additional, Restrepo, M. Adelaida, additional, Martínez Nieto, Lourdes, additional, Diez-Itza, Eliseo, additional, Rosemberg, Celia Renata, additional, Ezeizabarrena, M. José, additional, Almgren, Margareta, additional, Serrat, Elisabet, additional, Galeote, Miguel Angel, additional, Arias, Natalia, additional, Resches, Mariela, additional, and Andreu, Llorenç, additional

Published
2024
Full Text
View/download PDF

5. A novel method for engineering autologous non-thrombogenic in situ tissue-engineered blood vessels for arteriovenous grafting

Author

Geelhoed, W.J., primary, van der Bogt, K.E.A., additional, Rothuizen, T.C., additional, Damanik, F.F.R., additional, Hamming, J.F., additional, Mota, C.D., additional, van Agen, M.S., additional, de Boer, H.C., additional, Restrepo, M. Tobón, additional, Hinz, B., additional, Kislaya, A., additional, Poelma, C., additional, van Zonneveld, A.J., additional, Rabelink, T.J., additional, Moroni, L., additional, and Rotmans, J.I., additional

Published
2020
Full Text
View/download PDF

8. The management of community-acquired pneumonia in the elderly

Author

Faverio, P, Aliberti, S, Bellelli, G, Suigo, G, Lonni, S, Pesci, A, Restrepo, M, FAVERIO, PAOLA, ALIBERTI, STEFANO, BELLELLI, GIUSEPPE, SUIGO, GIULIA, PESCI, ALBERTO, Restrepo, M., Faverio, P, Aliberti, S, Bellelli, G, Suigo, G, Lonni, S, Pesci, A, Restrepo, M, FAVERIO, PAOLA, ALIBERTI, STEFANO, BELLELLI, GIUSEPPE, SUIGO, GIULIA, PESCI, ALBERTO, and Restrepo, M.

Abstract

Pneumonia is one of the main causes of morbidity and mortality in the elderly. The elderly population has exponentially increased in the last decades and the current epidemiological trends indicate that it is expected to further increase. Therefore, recognizing the special needs of older people is of paramount importance. In this review we address the main differences between elderly and adult patients with pneumonia. We focus on several aspects, including the atypical clinical presentation of pneumonia in the elderly, the methods to assess severity of illness, the appropriate setting of care, and the management of comorbidities. We also discuss how to approach the common complications of severe pneumonia, including acute respiratory failure and severe sepsis. Moreover, we debate whether or not elderly patients are at higher risk of infection due to multi-drug resistant pathogens and which risk factors should be considered when choosing the antibiotic therapy. We highlight the differences in the definition of clinical stability and treatment failure between adults and elderly patients. Finally, we review the main outcomes, preventive and supportive measures to be considered in elderly patients with pneumonia

Published
2014

16. Safety and Efficacy of Neoadjuvant Folfirinox in Patients (Pts) with Locally Advanced Pancreatic Adenocarcinoma (Lapc)

Author

Khushman, M.M., primary, Scherfenberg, N., additional, Hosein, P., additional, Velez, M., additional, Carcas Peirce, L., additional, Dammrich, D., additional, Hurtado-Cordovi, J., additional, Parajuli, R., additional, Pollack, T., additional, Harwood, A.P., additional, Macintyre, J., additional, Merchan, J., additional, Loaiza-Bonilla, A., additional, Akunyili, I.I., additional, Restrepo, M., additional, Narayanan, G., additional, Portelance, L., additional, Sleeman, D., additional, Levi, J., additional, and Rocha-Lima, C., additional

Published
2014
Full Text
View/download PDF

21. Treatment of paracoccidioidomycosis with ketoconazole: A three-year experience

Author

Mary A. Robledo, Luz Elena Cano, Iván Gómez, Maria D. Arango, Alejandro Sanín, Angela Restrepo M, and Fernando Gutiérrez

Subjects
Adult, Male, Drug, medicine.medical_specialty, Antifungal Agents, Scoring system, media_common.quotation_subject, First line, Piperazines, Recurrence, Oral administration, Internal medicine, medicine, Humans, Aged, media_common, business.industry, Paracoccidioidomycosis, Imidazoles, General Medicine, Middle Aged, medicine.disease, Complete resolution, Surgery, Ketoconazole, Toxicity, Drug Evaluation, Female, business, medicine.drug
Abstract

The results of ketoconazole therapy in 38 patients with active paracoccidioidomycosis are described. Treatment consisted of a 200 mg tablet a day for 6 months. Evaluation was accomplished by means of a scoring system and the results were as follows: none of the patients worsened during therapy, one was found to be unchanged, five had minor improvement, 30 had major improvement, and there was complete resolution of the pretherapy conditions in 13. These findings plus the lack of toxicity of the drug and the facility for oral administration, make of ketoconazole a first line drug for the treatment of paracoccidioidomycosis.

Published
1983

22. Post-therapy status of paracoccidioidomycosis treated with ketoconazole

Author

Alejandro Sanín, Angela Restrepo M, Maria D. Arango, Iván Gómez, Mary A. Robledo, Fernando Gutiérrez, and Luz Elena Cano

Subjects
Male, medicine.medical_specialty, Antifungal Agents, End of therapy, Paracoccidioidin, Gastroenterology, Piperazines, Decreased Antibody Activity, Paracoccidioidomicosis - Tratamiento, Recurrence, Internal medicine, medicine, Humans, Antibodies, Fungal, Paracoccidioidomycosis, business.industry, Immunologic Tests, Imidazoles, General Medicine, Skin test, Prognosis, medicine.disease, Surgery, Investigación aplicada, Ketoconazole, business, After treatment, Follow-Up Studies, medicine.drug
Abstract

Twenty-four paracoccidioidomycosis patients who completed a course of therapy with ketoconazole were followed for 12 months after treatment, and 10 of these patients were followed for 24 months. Only two of these patients relapsed; the remaining continued in remission. There were no fatalities. Immunologic tests showed decreased antibody activity and increased skin test reactivity to paracoccidioidin in comparison with the results obtained at the end of therapy. These findings indicate that ketoconazole therapy has improved the prognosis of patients with paracoccidioidomycosis. Se realizó un seguimiento de 24 pacientes con paracoccidioidomicosis que completaron un ciclo de terapia con ketoconazol durante 12 meses después del tratamiento, y 10 de estos pacientes se siguieron durante 24 meses. Solo dos de estos pacientes recayeron; el resto continuó en remisión. No hubo víctimas mortales. Las pruebas inmunológicas mostraron una disminución de la actividad de los anticuerpos y una mayor reactividad de las pruebas cutáneas a la paracoccidioidina en comparación con los resultados obtenidos al final de la terapia. Estos hallazgos indican que la terapia con ketoconazol ha mejorado el pronóstico de los pacientes con paracoccidioidomicosis.

Published
1983

23. MICONAZOLE IN PARACOCCIDIOIDOMYCOSIS

Author

D A Stevens and Angela Restrepo-M.

Subjects
medicine.medical_specialty, Miconazole, Paracoccidioidomycosis, business.industry, Imidazoles, General Medicine, medicine.disease, Dermatology, medicine, Humans, business, medicine.drug
Published
1979

Catalog

Books, media, physical & digital resources
See catalog results